Global HIV Therapy Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
LPI (LP Information)' newest research report, the “HIV Therapy Industry Forecast” looks at past sales and reviews total world HIV Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected HIV Therapy sales for 2023 through 2029. With HIV Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV Therapy industry.
This Insight Report provides a comprehensive analysis of the global HIV Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HIV Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global HIV Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV Therapy.
The global HIV Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for HIV Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for HIV Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for HIV Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key HIV Therapy players cover ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global HIV Therapy market?
What factors are driving HIV Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HIV Therapy market opportunities vary by end market size?
How does HIV Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
LPI (LP Information)' newest research report, the “HIV Therapy Industry Forecast” looks at past sales and reviews total world HIV Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected HIV Therapy sales for 2023 through 2029. With HIV Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV Therapy industry.
This Insight Report provides a comprehensive analysis of the global HIV Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HIV Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global HIV Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV Therapy.
The global HIV Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for HIV Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for HIV Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for HIV Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key HIV Therapy players cover ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ViiV Healthcare
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Merck Sharp & Dohme Corp.
- Bristol-Myers Squibb Company
- Janssen Pharmaceuticals, Inc.
- Boehringer Ingelheim International GmbH
- AbbVie Inc.
- Genentech, Inc.
- Mylan N.V.
What is the 10-year outlook for the global HIV Therapy market?
What factors are driving HIV Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HIV Therapy market opportunities vary by end market size?
How does HIV Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HIV Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for HIV Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for HIV Therapy by Country/Region, 2018, 2022 & 2029
2.2 HIV Therapy Segment by Type
2.2.1 Integrase Inhibitors
2.2.2 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2.2.3 Combination HIV Medicines
2.2.4 Others
2.3 HIV Therapy Sales by Type
2.3.1 Global HIV Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global HIV Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global HIV Therapy Sale Price by Type (2018-2023)
2.4 HIV Therapy Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 HIV Therapy Sales by Application
2.5.1 Global HIV Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global HIV Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global HIV Therapy Sale Price by Application (2018-2023)
3 GLOBAL HIV THERAPY BY COMPANY
3.1 Global HIV Therapy Breakdown Data by Company
3.1.1 Global HIV Therapy Annual Sales by Company (2018-2023)
3.1.2 Global HIV Therapy Sales Market Share by Company (2018-2023)
3.2 Global HIV Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global HIV Therapy Revenue by Company (2018-2023)
3.2.2 Global HIV Therapy Revenue Market Share by Company (2018-2023)
3.3 Global HIV Therapy Sale Price by Company
3.4 Key Manufacturers HIV Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HIV Therapy Product Location Distribution
3.4.2 Players HIV Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HIV THERAPY BY GEOGRAPHIC REGION
4.1 World Historic HIV Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global HIV Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global HIV Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HIV Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global HIV Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global HIV Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas HIV Therapy Sales Growth
4.4 APAC HIV Therapy Sales Growth
4.5 Europe HIV Therapy Sales Growth
4.6 Middle East & Africa HIV Therapy Sales Growth
5 AMERICAS
5.1 Americas HIV Therapy Sales by Country
5.1.1 Americas HIV Therapy Sales by Country (2018-2023)
5.1.2 Americas HIV Therapy Revenue by Country (2018-2023)
5.2 Americas HIV Therapy Sales by Type
5.3 Americas HIV Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Therapy Sales by Region
6.1.1 APAC HIV Therapy Sales by Region (2018-2023)
6.1.2 APAC HIV Therapy Revenue by Region (2018-2023)
6.2 APAC HIV Therapy Sales by Type
6.3 APAC HIV Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HIV Therapy by Country
7.1.1 Europe HIV Therapy Sales by Country (2018-2023)
7.1.2 Europe HIV Therapy Revenue by Country (2018-2023)
7.2 Europe HIV Therapy Sales by Type
7.3 Europe HIV Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HIV Therapy by Country
8.1.1 Middle East & Africa HIV Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa HIV Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa HIV Therapy Sales by Type
8.3 Middle East & Africa HIV Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HIV Therapy
10.3 Manufacturing Process Analysis of HIV Therapy
10.4 Industry Chain Structure of HIV Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HIV Therapy Distributors
11.3 HIV Therapy Customer
12 WORLD FORECAST REVIEW FOR HIV THERAPY BY GEOGRAPHIC REGION
12.1 Global HIV Therapy Market Size Forecast by Region
12.1.1 Global HIV Therapy Forecast by Region (2024-2029)
12.1.2 Global HIV Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HIV Therapy Forecast by Type
12.7 Global HIV Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ViiV Healthcare
13.1.1 ViiV Healthcare Company Information
13.1.2 ViiV Healthcare HIV Therapy Product Portfolios and Specifications
13.1.3 ViiV Healthcare HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ViiV Healthcare Main Business Overview
13.1.5 ViiV Healthcare Latest Developments
13.2 Gilead Sciences, Inc.
13.2.1 Gilead Sciences, Inc. Company Information
13.2.2 Gilead Sciences, Inc. HIV Therapy Product Portfolios and Specifications
13.2.3 Gilead Sciences, Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Gilead Sciences, Inc. Main Business Overview
13.2.5 Gilead Sciences, Inc. Latest Developments
13.3 GlaxoSmithKline Plc
13.3.1 GlaxoSmithKline Plc Company Information
13.3.2 GlaxoSmithKline Plc HIV Therapy Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Plc HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Plc Main Business Overview
13.3.5 GlaxoSmithKline Plc Latest Developments
13.4 Merck Sharp & Dohme Corp.
13.4.1 Merck Sharp & Dohme Corp. Company Information
13.4.2 Merck Sharp & Dohme Corp. HIV Therapy Product Portfolios and Specifications
13.4.3 Merck Sharp & Dohme Corp. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Sharp & Dohme Corp. Main Business Overview
13.4.5 Merck Sharp & Dohme Corp. Latest Developments
13.5 Bristol-Myers Squibb Company
13.5.1 Bristol-Myers Squibb Company Company Information
13.5.2 Bristol-Myers Squibb Company HIV Therapy Product Portfolios and Specifications
13.5.3 Bristol-Myers Squibb Company HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bristol-Myers Squibb Company Main Business Overview
13.5.5 Bristol-Myers Squibb Company Latest Developments
13.6 Janssen Pharmaceuticals, Inc.
13.6.1 Janssen Pharmaceuticals, Inc. Company Information
13.6.2 Janssen Pharmaceuticals, Inc. HIV Therapy Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Janssen Pharmaceuticals, Inc. Main Business Overview
13.6.5 Janssen Pharmaceuticals, Inc. Latest Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Boehringer Ingelheim International GmbH Company Information
13.7.2 Boehringer Ingelheim International GmbH HIV Therapy Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim International GmbH HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boehringer Ingelheim International GmbH Main Business Overview
13.7.5 Boehringer Ingelheim International GmbH Latest Developments
13.8 AbbVie Inc.
13.8.1 AbbVie Inc. Company Information
13.8.2 AbbVie Inc. HIV Therapy Product Portfolios and Specifications
13.8.3 AbbVie Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AbbVie Inc. Main Business Overview
13.8.5 AbbVie Inc. Latest Developments
13.9 Genentech, Inc.
13.9.1 Genentech, Inc. Company Information
13.9.2 Genentech, Inc. HIV Therapy Product Portfolios and Specifications
13.9.3 Genentech, Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Genentech, Inc. Main Business Overview
13.9.5 Genentech, Inc. Latest Developments
13.10 Mylan N.V.
13.10.1 Mylan N.V. Company Information
13.10.2 Mylan N.V. HIV Therapy Product Portfolios and Specifications
13.10.3 Mylan N.V. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mylan N.V. Main Business Overview
13.10.5 Mylan N.V. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HIV Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for HIV Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for HIV Therapy by Country/Region, 2018, 2022 & 2029
2.2 HIV Therapy Segment by Type
2.2.1 Integrase Inhibitors
2.2.2 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2.2.3 Combination HIV Medicines
2.2.4 Others
2.3 HIV Therapy Sales by Type
2.3.1 Global HIV Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global HIV Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global HIV Therapy Sale Price by Type (2018-2023)
2.4 HIV Therapy Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 HIV Therapy Sales by Application
2.5.1 Global HIV Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global HIV Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global HIV Therapy Sale Price by Application (2018-2023)
3 GLOBAL HIV THERAPY BY COMPANY
3.1 Global HIV Therapy Breakdown Data by Company
3.1.1 Global HIV Therapy Annual Sales by Company (2018-2023)
3.1.2 Global HIV Therapy Sales Market Share by Company (2018-2023)
3.2 Global HIV Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global HIV Therapy Revenue by Company (2018-2023)
3.2.2 Global HIV Therapy Revenue Market Share by Company (2018-2023)
3.3 Global HIV Therapy Sale Price by Company
3.4 Key Manufacturers HIV Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HIV Therapy Product Location Distribution
3.4.2 Players HIV Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HIV THERAPY BY GEOGRAPHIC REGION
4.1 World Historic HIV Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global HIV Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global HIV Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HIV Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global HIV Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global HIV Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas HIV Therapy Sales Growth
4.4 APAC HIV Therapy Sales Growth
4.5 Europe HIV Therapy Sales Growth
4.6 Middle East & Africa HIV Therapy Sales Growth
5 AMERICAS
5.1 Americas HIV Therapy Sales by Country
5.1.1 Americas HIV Therapy Sales by Country (2018-2023)
5.1.2 Americas HIV Therapy Revenue by Country (2018-2023)
5.2 Americas HIV Therapy Sales by Type
5.3 Americas HIV Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Therapy Sales by Region
6.1.1 APAC HIV Therapy Sales by Region (2018-2023)
6.1.2 APAC HIV Therapy Revenue by Region (2018-2023)
6.2 APAC HIV Therapy Sales by Type
6.3 APAC HIV Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HIV Therapy by Country
7.1.1 Europe HIV Therapy Sales by Country (2018-2023)
7.1.2 Europe HIV Therapy Revenue by Country (2018-2023)
7.2 Europe HIV Therapy Sales by Type
7.3 Europe HIV Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HIV Therapy by Country
8.1.1 Middle East & Africa HIV Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa HIV Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa HIV Therapy Sales by Type
8.3 Middle East & Africa HIV Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HIV Therapy
10.3 Manufacturing Process Analysis of HIV Therapy
10.4 Industry Chain Structure of HIV Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HIV Therapy Distributors
11.3 HIV Therapy Customer
12 WORLD FORECAST REVIEW FOR HIV THERAPY BY GEOGRAPHIC REGION
12.1 Global HIV Therapy Market Size Forecast by Region
12.1.1 Global HIV Therapy Forecast by Region (2024-2029)
12.1.2 Global HIV Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HIV Therapy Forecast by Type
12.7 Global HIV Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ViiV Healthcare
13.1.1 ViiV Healthcare Company Information
13.1.2 ViiV Healthcare HIV Therapy Product Portfolios and Specifications
13.1.3 ViiV Healthcare HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ViiV Healthcare Main Business Overview
13.1.5 ViiV Healthcare Latest Developments
13.2 Gilead Sciences, Inc.
13.2.1 Gilead Sciences, Inc. Company Information
13.2.2 Gilead Sciences, Inc. HIV Therapy Product Portfolios and Specifications
13.2.3 Gilead Sciences, Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Gilead Sciences, Inc. Main Business Overview
13.2.5 Gilead Sciences, Inc. Latest Developments
13.3 GlaxoSmithKline Plc
13.3.1 GlaxoSmithKline Plc Company Information
13.3.2 GlaxoSmithKline Plc HIV Therapy Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Plc HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Plc Main Business Overview
13.3.5 GlaxoSmithKline Plc Latest Developments
13.4 Merck Sharp & Dohme Corp.
13.4.1 Merck Sharp & Dohme Corp. Company Information
13.4.2 Merck Sharp & Dohme Corp. HIV Therapy Product Portfolios and Specifications
13.4.3 Merck Sharp & Dohme Corp. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Sharp & Dohme Corp. Main Business Overview
13.4.5 Merck Sharp & Dohme Corp. Latest Developments
13.5 Bristol-Myers Squibb Company
13.5.1 Bristol-Myers Squibb Company Company Information
13.5.2 Bristol-Myers Squibb Company HIV Therapy Product Portfolios and Specifications
13.5.3 Bristol-Myers Squibb Company HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bristol-Myers Squibb Company Main Business Overview
13.5.5 Bristol-Myers Squibb Company Latest Developments
13.6 Janssen Pharmaceuticals, Inc.
13.6.1 Janssen Pharmaceuticals, Inc. Company Information
13.6.2 Janssen Pharmaceuticals, Inc. HIV Therapy Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Janssen Pharmaceuticals, Inc. Main Business Overview
13.6.5 Janssen Pharmaceuticals, Inc. Latest Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Boehringer Ingelheim International GmbH Company Information
13.7.2 Boehringer Ingelheim International GmbH HIV Therapy Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim International GmbH HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boehringer Ingelheim International GmbH Main Business Overview
13.7.5 Boehringer Ingelheim International GmbH Latest Developments
13.8 AbbVie Inc.
13.8.1 AbbVie Inc. Company Information
13.8.2 AbbVie Inc. HIV Therapy Product Portfolios and Specifications
13.8.3 AbbVie Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AbbVie Inc. Main Business Overview
13.8.5 AbbVie Inc. Latest Developments
13.9 Genentech, Inc.
13.9.1 Genentech, Inc. Company Information
13.9.2 Genentech, Inc. HIV Therapy Product Portfolios and Specifications
13.9.3 Genentech, Inc. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Genentech, Inc. Main Business Overview
13.9.5 Genentech, Inc. Latest Developments
13.10 Mylan N.V.
13.10.1 Mylan N.V. Company Information
13.10.2 Mylan N.V. HIV Therapy Product Portfolios and Specifications
13.10.3 Mylan N.V. HIV Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mylan N.V. Main Business Overview
13.10.5 Mylan N.V. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HIV Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. HIV Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Integrase Inhibitors
Table 4. Major Players of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 5. Major Players of Combination HIV Medicines
Table 6. Major Players of Others
Table 7. Global HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 8. Global HIV Therapy Sales Market Share by Type (2018-2023)
Table 9. Global HIV Therapy Revenue by Type (2018-2023) & ($ million)
Table 10. Global HIV Therapy Revenue Market Share by Type (2018-2023)
Table 11. Global HIV Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 13. Global HIV Therapy Sales Market Share by Application (2018-2023)
Table 14. Global HIV Therapy Revenue by Application (2018-2023)
Table 15. Global HIV Therapy Revenue Market Share by Application (2018-2023)
Table 16. Global HIV Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global HIV Therapy Sales by Company (2018-2023) & (K Units)
Table 18. Global HIV Therapy Sales Market Share by Company (2018-2023)
Table 19. Global HIV Therapy Revenue by Company (2018-2023) ($ Millions)
Table 20. Global HIV Therapy Revenue Market Share by Company (2018-2023)
Table 21. Global HIV Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers HIV Therapy Producing Area Distribution and Sales Area
Table 23. Players HIV Therapy Products Offered
Table 24. HIV Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global HIV Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global HIV Therapy Sales Market Share Geographic Region (2018-2023)
Table 29. Global HIV Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global HIV Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global HIV Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global HIV Therapy Sales Market Share by Country/Region (2018-2023)
Table 33. Global HIV Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global HIV Therapy Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas HIV Therapy Sales by Country (2018-2023) & (K Units)
Table 36. Americas HIV Therapy Sales Market Share by Country (2018-2023)
Table 37. Americas HIV Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas HIV Therapy Revenue Market Share by Country (2018-2023)
Table 39. Americas HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 40. Americas HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 41. APAC HIV Therapy Sales by Region (2018-2023) & (K Units)
Table 42. APAC HIV Therapy Sales Market Share by Region (2018-2023)
Table 43. APAC HIV Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC HIV Therapy Revenue Market Share by Region (2018-2023)
Table 45. APAC HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 46. APAC HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 47. Europe HIV Therapy Sales by Country (2018-2023) & (K Units)
Table 48. Europe HIV Therapy Sales Market Share by Country (2018-2023)
Table 49. Europe HIV Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe HIV Therapy Revenue Market Share by Country (2018-2023)
Table 51. Europe HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 52. Europe HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa HIV Therapy Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa HIV Therapy Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa HIV Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa HIV Therapy Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of HIV Therapy
Table 60. Key Market Challenges & Risks of HIV Therapy
Table 61. Key Industry Trends of HIV Therapy
Table 62. HIV Therapy Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. HIV Therapy Distributors List
Table 65. HIV Therapy Customer List
Table 66. Global HIV Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global HIV Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas HIV Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas HIV Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC HIV Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC HIV Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe HIV Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe HIV Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa HIV Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa HIV Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global HIV Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global HIV Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global HIV Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global HIV Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. ViiV Healthcare Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 81. ViiV Healthcare HIV Therapy Product Portfolios and Specifications
Table 82. ViiV Healthcare HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. ViiV Healthcare Main Business
Table 84. ViiV Healthcare Latest Developments
Table 85. Gilead Sciences, Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 86. Gilead Sciences, Inc. HIV Therapy Product Portfolios and Specifications
Table 87. Gilead Sciences, Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Gilead Sciences, Inc. Main Business
Table 89. Gilead Sciences, Inc. Latest Developments
Table 90. GlaxoSmithKline Plc Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 91. GlaxoSmithKline Plc HIV Therapy Product Portfolios and Specifications
Table 92. GlaxoSmithKline Plc HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Plc Main Business
Table 94. GlaxoSmithKline Plc Latest Developments
Table 95. Merck Sharp & Dohme Corp. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck Sharp & Dohme Corp. HIV Therapy Product Portfolios and Specifications
Table 97. Merck Sharp & Dohme Corp. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Merck Sharp & Dohme Corp. Main Business
Table 99. Merck Sharp & Dohme Corp. Latest Developments
Table 100. Bristol-Myers Squibb Company Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 101. Bristol-Myers Squibb Company HIV Therapy Product Portfolios and Specifications
Table 102. Bristol-Myers Squibb Company HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Bristol-Myers Squibb Company Main Business
Table 104. Bristol-Myers Squibb Company Latest Developments
Table 105. Janssen Pharmaceuticals, Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 106. Janssen Pharmaceuticals, Inc. HIV Therapy Product Portfolios and Specifications
Table 107. Janssen Pharmaceuticals, Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Janssen Pharmaceuticals, Inc. Main Business
Table 109. Janssen Pharmaceuticals, Inc. Latest Developments
Table 110. Boehringer Ingelheim International GmbH Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 111. Boehringer Ingelheim International GmbH HIV Therapy Product Portfolios and Specifications
Table 112. Boehringer Ingelheim International GmbH HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Boehringer Ingelheim International GmbH Main Business
Table 114. Boehringer Ingelheim International GmbH Latest Developments
Table 115. AbbVie Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 116. AbbVie Inc. HIV Therapy Product Portfolios and Specifications
Table 117. AbbVie Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. AbbVie Inc. Main Business
Table 119. AbbVie Inc. Latest Developments
Table 120. Genentech, Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 121. Genentech, Inc. HIV Therapy Product Portfolios and Specifications
Table 122. Genentech, Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Genentech, Inc. Main Business
Table 124. Genentech, Inc. Latest Developments
Table 125. Mylan N.V. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 126. Mylan N.V. HIV Therapy Product Portfolios and Specifications
Table 127. Mylan N.V. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Mylan N.V. Main Business
Table 129. Mylan N.V. Latest Developments
Table 1. HIV Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. HIV Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Integrase Inhibitors
Table 4. Major Players of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 5. Major Players of Combination HIV Medicines
Table 6. Major Players of Others
Table 7. Global HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 8. Global HIV Therapy Sales Market Share by Type (2018-2023)
Table 9. Global HIV Therapy Revenue by Type (2018-2023) & ($ million)
Table 10. Global HIV Therapy Revenue Market Share by Type (2018-2023)
Table 11. Global HIV Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 13. Global HIV Therapy Sales Market Share by Application (2018-2023)
Table 14. Global HIV Therapy Revenue by Application (2018-2023)
Table 15. Global HIV Therapy Revenue Market Share by Application (2018-2023)
Table 16. Global HIV Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global HIV Therapy Sales by Company (2018-2023) & (K Units)
Table 18. Global HIV Therapy Sales Market Share by Company (2018-2023)
Table 19. Global HIV Therapy Revenue by Company (2018-2023) ($ Millions)
Table 20. Global HIV Therapy Revenue Market Share by Company (2018-2023)
Table 21. Global HIV Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers HIV Therapy Producing Area Distribution and Sales Area
Table 23. Players HIV Therapy Products Offered
Table 24. HIV Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global HIV Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global HIV Therapy Sales Market Share Geographic Region (2018-2023)
Table 29. Global HIV Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global HIV Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global HIV Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global HIV Therapy Sales Market Share by Country/Region (2018-2023)
Table 33. Global HIV Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global HIV Therapy Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas HIV Therapy Sales by Country (2018-2023) & (K Units)
Table 36. Americas HIV Therapy Sales Market Share by Country (2018-2023)
Table 37. Americas HIV Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas HIV Therapy Revenue Market Share by Country (2018-2023)
Table 39. Americas HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 40. Americas HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 41. APAC HIV Therapy Sales by Region (2018-2023) & (K Units)
Table 42. APAC HIV Therapy Sales Market Share by Region (2018-2023)
Table 43. APAC HIV Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC HIV Therapy Revenue Market Share by Region (2018-2023)
Table 45. APAC HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 46. APAC HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 47. Europe HIV Therapy Sales by Country (2018-2023) & (K Units)
Table 48. Europe HIV Therapy Sales Market Share by Country (2018-2023)
Table 49. Europe HIV Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe HIV Therapy Revenue Market Share by Country (2018-2023)
Table 51. Europe HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 52. Europe HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa HIV Therapy Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa HIV Therapy Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa HIV Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa HIV Therapy Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa HIV Therapy Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa HIV Therapy Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of HIV Therapy
Table 60. Key Market Challenges & Risks of HIV Therapy
Table 61. Key Industry Trends of HIV Therapy
Table 62. HIV Therapy Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. HIV Therapy Distributors List
Table 65. HIV Therapy Customer List
Table 66. Global HIV Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global HIV Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas HIV Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas HIV Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC HIV Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC HIV Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe HIV Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe HIV Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa HIV Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa HIV Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global HIV Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global HIV Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global HIV Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global HIV Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. ViiV Healthcare Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 81. ViiV Healthcare HIV Therapy Product Portfolios and Specifications
Table 82. ViiV Healthcare HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. ViiV Healthcare Main Business
Table 84. ViiV Healthcare Latest Developments
Table 85. Gilead Sciences, Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 86. Gilead Sciences, Inc. HIV Therapy Product Portfolios and Specifications
Table 87. Gilead Sciences, Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Gilead Sciences, Inc. Main Business
Table 89. Gilead Sciences, Inc. Latest Developments
Table 90. GlaxoSmithKline Plc Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 91. GlaxoSmithKline Plc HIV Therapy Product Portfolios and Specifications
Table 92. GlaxoSmithKline Plc HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Plc Main Business
Table 94. GlaxoSmithKline Plc Latest Developments
Table 95. Merck Sharp & Dohme Corp. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck Sharp & Dohme Corp. HIV Therapy Product Portfolios and Specifications
Table 97. Merck Sharp & Dohme Corp. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Merck Sharp & Dohme Corp. Main Business
Table 99. Merck Sharp & Dohme Corp. Latest Developments
Table 100. Bristol-Myers Squibb Company Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 101. Bristol-Myers Squibb Company HIV Therapy Product Portfolios and Specifications
Table 102. Bristol-Myers Squibb Company HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Bristol-Myers Squibb Company Main Business
Table 104. Bristol-Myers Squibb Company Latest Developments
Table 105. Janssen Pharmaceuticals, Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 106. Janssen Pharmaceuticals, Inc. HIV Therapy Product Portfolios and Specifications
Table 107. Janssen Pharmaceuticals, Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Janssen Pharmaceuticals, Inc. Main Business
Table 109. Janssen Pharmaceuticals, Inc. Latest Developments
Table 110. Boehringer Ingelheim International GmbH Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 111. Boehringer Ingelheim International GmbH HIV Therapy Product Portfolios and Specifications
Table 112. Boehringer Ingelheim International GmbH HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Boehringer Ingelheim International GmbH Main Business
Table 114. Boehringer Ingelheim International GmbH Latest Developments
Table 115. AbbVie Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 116. AbbVie Inc. HIV Therapy Product Portfolios and Specifications
Table 117. AbbVie Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. AbbVie Inc. Main Business
Table 119. AbbVie Inc. Latest Developments
Table 120. Genentech, Inc. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 121. Genentech, Inc. HIV Therapy Product Portfolios and Specifications
Table 122. Genentech, Inc. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Genentech, Inc. Main Business
Table 124. Genentech, Inc. Latest Developments
Table 125. Mylan N.V. Basic Information, HIV Therapy Manufacturing Base, Sales Area and Its Competitors
Table 126. Mylan N.V. HIV Therapy Product Portfolios and Specifications
Table 127. Mylan N.V. HIV Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Mylan N.V. Main Business
Table 129. Mylan N.V. Latest Developments
LIST OF FIGURES
Figure 1. Picture of HIV Therapy
Figure 2. HIV Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HIV Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global HIV Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. HIV Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Integrase Inhibitors
Figure 10. Product Picture of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Figure 11. Product Picture of Combination HIV Medicines
Figure 12. Product Picture of Others
Figure 13. Global HIV Therapy Sales Market Share by Type in 2022
Figure 14. Global HIV Therapy Revenue Market Share by Type (2018-2023)
Figure 15. HIV Therapy Consumed in Hospital Pharmacies
Figure 16. Global HIV Therapy Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 17. HIV Therapy Consumed in Retail Pharmacies
Figure 18. Global HIV Therapy Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 19. HIV Therapy Consumed in Online Pharmacies
Figure 20. Global HIV Therapy Market: Online Pharmacies (2018-2023) & (K Units)
Figure 21. HIV Therapy Consumed in Others
Figure 22. Global HIV Therapy Market: Others (2018-2023) & (K Units)
Figure 23. Global HIV Therapy Sales Market Share by Application (2022)
Figure 24. Global HIV Therapy Revenue Market Share by Application in 2022
Figure 25. HIV Therapy Sales Market by Company in 2022 (K Units)
Figure 26. Global HIV Therapy Sales Market Share by Company in 2022
Figure 27. HIV Therapy Revenue Market by Company in 2022 ($ Million)
Figure 28. Global HIV Therapy Revenue Market Share by Company in 2022
Figure 29. Global HIV Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global HIV Therapy Revenue Market Share by Geographic Region in 2022
Figure 31. Americas HIV Therapy Sales 2018-2023 (K Units)
Figure 32. Americas HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 33. APAC HIV Therapy Sales 2018-2023 (K Units)
Figure 34. APAC HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 35. Europe HIV Therapy Sales 2018-2023 (K Units)
Figure 36. Europe HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa HIV Therapy Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 39. Americas HIV Therapy Sales Market Share by Country in 2022
Figure 40. Americas HIV Therapy Revenue Market Share by Country in 2022
Figure 41. Americas HIV Therapy Sales Market Share by Type (2018-2023)
Figure 42. Americas HIV Therapy Sales Market Share by Application (2018-2023)
Figure 43. United States HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC HIV Therapy Sales Market Share by Region in 2022
Figure 48. APAC HIV Therapy Revenue Market Share by Regions in 2022
Figure 49. APAC HIV Therapy Sales Market Share by Type (2018-2023)
Figure 50. APAC HIV Therapy Sales Market Share by Application (2018-2023)
Figure 51. China HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 55. India HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe HIV Therapy Sales Market Share by Country in 2022
Figure 59. Europe HIV Therapy Revenue Market Share by Country in 2022
Figure 60. Europe HIV Therapy Sales Market Share by Type (2018-2023)
Figure 61. Europe HIV Therapy Sales Market Share by Application (2018-2023)
Figure 62. Germany HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 63. France HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa HIV Therapy Sales Market Share by Country in 2022
Figure 68. Middle East & Africa HIV Therapy Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa HIV Therapy Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa HIV Therapy Sales Market Share by Application (2018-2023)
Figure 71. Egypt HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of HIV Therapy in 2022
Figure 77. Manufacturing Process Analysis of HIV Therapy
Figure 78. Industry Chain Structure of HIV Therapy
Figure 79. Channels of Distribution
Figure 80. Global HIV Therapy Sales Market Forecast by Region (2024-2029)
Figure 81. Global HIV Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global HIV Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global HIV Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global HIV Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global HIV Therapy Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of HIV Therapy
Figure 2. HIV Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HIV Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global HIV Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. HIV Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Integrase Inhibitors
Figure 10. Product Picture of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Figure 11. Product Picture of Combination HIV Medicines
Figure 12. Product Picture of Others
Figure 13. Global HIV Therapy Sales Market Share by Type in 2022
Figure 14. Global HIV Therapy Revenue Market Share by Type (2018-2023)
Figure 15. HIV Therapy Consumed in Hospital Pharmacies
Figure 16. Global HIV Therapy Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 17. HIV Therapy Consumed in Retail Pharmacies
Figure 18. Global HIV Therapy Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 19. HIV Therapy Consumed in Online Pharmacies
Figure 20. Global HIV Therapy Market: Online Pharmacies (2018-2023) & (K Units)
Figure 21. HIV Therapy Consumed in Others
Figure 22. Global HIV Therapy Market: Others (2018-2023) & (K Units)
Figure 23. Global HIV Therapy Sales Market Share by Application (2022)
Figure 24. Global HIV Therapy Revenue Market Share by Application in 2022
Figure 25. HIV Therapy Sales Market by Company in 2022 (K Units)
Figure 26. Global HIV Therapy Sales Market Share by Company in 2022
Figure 27. HIV Therapy Revenue Market by Company in 2022 ($ Million)
Figure 28. Global HIV Therapy Revenue Market Share by Company in 2022
Figure 29. Global HIV Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global HIV Therapy Revenue Market Share by Geographic Region in 2022
Figure 31. Americas HIV Therapy Sales 2018-2023 (K Units)
Figure 32. Americas HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 33. APAC HIV Therapy Sales 2018-2023 (K Units)
Figure 34. APAC HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 35. Europe HIV Therapy Sales 2018-2023 (K Units)
Figure 36. Europe HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa HIV Therapy Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa HIV Therapy Revenue 2018-2023 ($ Millions)
Figure 39. Americas HIV Therapy Sales Market Share by Country in 2022
Figure 40. Americas HIV Therapy Revenue Market Share by Country in 2022
Figure 41. Americas HIV Therapy Sales Market Share by Type (2018-2023)
Figure 42. Americas HIV Therapy Sales Market Share by Application (2018-2023)
Figure 43. United States HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC HIV Therapy Sales Market Share by Region in 2022
Figure 48. APAC HIV Therapy Revenue Market Share by Regions in 2022
Figure 49. APAC HIV Therapy Sales Market Share by Type (2018-2023)
Figure 50. APAC HIV Therapy Sales Market Share by Application (2018-2023)
Figure 51. China HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 55. India HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe HIV Therapy Sales Market Share by Country in 2022
Figure 59. Europe HIV Therapy Revenue Market Share by Country in 2022
Figure 60. Europe HIV Therapy Sales Market Share by Type (2018-2023)
Figure 61. Europe HIV Therapy Sales Market Share by Application (2018-2023)
Figure 62. Germany HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 63. France HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa HIV Therapy Sales Market Share by Country in 2022
Figure 68. Middle East & Africa HIV Therapy Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa HIV Therapy Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa HIV Therapy Sales Market Share by Application (2018-2023)
Figure 71. Egypt HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country HIV Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of HIV Therapy in 2022
Figure 77. Manufacturing Process Analysis of HIV Therapy
Figure 78. Industry Chain Structure of HIV Therapy
Figure 79. Channels of Distribution
Figure 80. Global HIV Therapy Sales Market Forecast by Region (2024-2029)
Figure 81. Global HIV Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global HIV Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global HIV Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global HIV Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global HIV Therapy Revenue Market Share Forecast by Application (2024-2029)
